Compare Acadia Healthcare Company Inc (ACHC) vs Raytheon Technologies Corp (RTX) Price & Performance

ACHC trades at $31.09, down 2.57% today but maintains a bullish technical outlook with strong moving average support. The company shows operational strength with three consecutive earnings beats, though profitability remains challenged with a -32.84% net margin. Analyst consensus is strongly bullish with 68% buy ratings, while recent news highlights the company's strategic shift toward profitability and rising behavioral health demand.

The stock presents a mixed opportunity with strong technical momentum and analyst support offset by persistent profitability challenges. Key catalysts include continued earnings outperformance and successful execution of the turnaround strategy, while risks center on margin pressures and high short interest that could limit upside potential.

RTX trades at $194.91, down 3.21% on the day, but maintains strong fundamental momentum with three consecutive quarterly earnings beats and a bullish technical outlook. The defense contractor shows robust revenue growth from $67.1B in 2022 to $88.6B in 2025, with net income margin expanding to 8.03%. Recent contract wins including a $515 million Navy radar award and expanded manufacturing capacity in Poland support continued growth prospects.

With 69% analyst buy ratings and a $213 consensus price target suggesting 9% upside, RTX offers exposure to elevated defense spending. Key risks include execution challenges in scaling munitions production and potential defense budget volatility. The stock's 37.68 P/E ratio appears elevated but is justified by accelerating earnings growth and strong contract backlog.